MetaVia Inc. — Director's Dealing 2017

Aug 2, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Gemphire Therapeutics Inc. (GEMP)
CIK: 0001638287
Period of Report: 2017-07-31

Reporting Person: Bisgaier Charles PhD (Director, Chief Scientific Off. & Chair, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-31	Common Stock	M	4474	$1.344	Acquired	1248914	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-07-31	Employee Stock Option (right to buy)	$1.344	M	4474	Disposed	2025-06-28	Common Stock (4474)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	82220	Indirect
Common Stock	19228	Indirect

Footnotes

F1: These shares are indirectly owned by the reporting person as trustee of The Charles L. Bisgaier Trust.